
























Reporting key details of respondent-driven sampling (RDS) survey implementation and 
analysis is essential for assessing the quality of RDS surveys. RDS is both a recruitment 
and analytic method and, as such, it is important to adequately describe both aspects in 
publications. We extracted data from peer-reviewed literature published through 
September, 2013 that reported collected biological specimens using RDS. We identified 
151 eligible peer-reviewed articles describing 222 surveys conducted in seven regions 
throughout the world. Most published surveys reported basic implementation information 
such as survey city, country, year, population sampled, interview method, and final 
sample size. However, many surveys did not report essential methodological and 
analytical information for assessing RDS survey quality, including number of recruitment 
sites, seeds at start and end, maximum number of waves, and whether data were adjusted 
for network size. Understanding the quality of data collection and analysis in RDS is 
useful to effectively plan for public health service delivery and funding priorities. 
INTRODUCTION 
The first respondent-driven sampling (RDS) surveys to assess HIV prevalence in 
addition to risk behaviors were conducted in 2004 (1–3). Since then hundreds of 
surveys have been conducted worldwide to capture data from populations considered at 
higher risk for HIV exposure, including people who inject drugs (PWID), men who have 
sex with men (MSM), female sex workers (FSW), and other populations without a 
readily available sampling frame (4–6). Over the past decade, many organizations, 
including the U.S. Centers for Disease Control and Prevention, UNAIDS, WHO, Global 
Fund and others have endorsed the use of RDS to establish baseline and trend 
measurements of HIV and other infections (Syphilis, Hepatitis, etc.) prevalence, risk 
behaviors, and program impact through biological and behavioral surveys (6–9).  
RDS is an important recruitment and analysis tools for sampling populations with 
no sampling frame that are linked through social networks, including those considered 
“hard-to-reach” due to stigma and the practice of illegal behaviors (4–6). RDS, a chain-
referral sampling technique, uses statistical adjustments for network sizes and 
recruitment effort to produce estimates representative of a population’s network. 
Beginning with a set number of participants, “seeds”, selected purposefully by the 
research team from the target population, RDS builds a sample based on the 
recruitment of individuals with pre-existing relationships. Using a limited number of 
coupons for each participant limits the possibility of overrepresentation of those with 
more ties to others in the population. Providing ‘incentives’ for those participating in and 
for recruiting peers into the survey helps ensure ongoing participation and recruitment. 
Ideally, this process results in long recruitment chains made up of numerous “waves” of 
recruits (10,14). As recruitment chains lengthen, the structure of the sample becomes 
less dependent on the purposefully selected seeds and more increasingly similar to the 
population being sampled.  
In addition to these implementation steps, RDS is premised upon several 
assumptions, most importantly, random walk models (10). Briefly, these assumptions 
include 1) reciprocal ties between respondents (i.e., know one another as members of 
the sampled population); 2) respondents are connected by a single network component; 
3) sampling occurs with replacement; 4) respondents provide accurate personal 
network sizes (i.e., number of relatives, friends, and acquaintances they know from the 
sampled population); 5) peers are recruited randomly from the recruiter’s network; and, 
6) each respondent can recruit at least one peer (11). RDS also involves a complex 
analytical component crucial for generating population estimates and confidence 
intervals using data collected about each participant’s social network size (10–14). 
Estimates generated through RDS should allow for inferences about the network of the 
population being sampled.  
Findings from surveys purporting to use RDS are vital for developing national 
and international policies, guiding service delivery, informing budgets and dictating 
funding priorities. Quality reporting of data collected and analyzed using RDS methods 
allows users to assess their usefulness in decision making. However, there is ample 
potential for bias when using this method, many of which are related to implementation 
and analytical failures (15–20). The allure of RDS as a more robust alternative to 
convenience snowball sampling methods has resulted in partial incorporation of RDS 
techniques (i.e., the use of coupons) while ignoring some of the more complex aspects 
which ensure the mitigation of chain referral related biases (13). Indeed, numerous 
published surveys report having used RDS, but present insufficient methodological and 
analytical information to support this assertion (21).  
Building upon the STROBE RDS guidelines (22) to recommend improvements in 
the reporting of survey data, we extracted peer-reviewed literature that reported using 
RDS for collecting HIV and other infections biological and behavioral data through 
September, 2013. Specifically, we evaluate a set of general and RDS-specific survey 
indicators based on the STROBE RDS guidelines (21,22) to describe the extent, 
consistency, and changes over time for planning, implementation, and analysis as 
reported in peer reviewed journals. In addition, we provide reasons why some published 
surveys were not included in the extraction and examples of surveys that reported using 
RDS when, in fact, evidence suggests they did not. We hope to build upon other efforts 
to increase accuracy in conducting RDS and to encourage more thorough and 

























Africa                                 
Kenya, Kisumu(23)  2008  FSW  Yes  1  ACASI  15  NR  4.00  1.25  480  4
Nigeria, Abuja(24)  2010  MSM  NR  NR  ACASI/SA  NR  NR  NR  NR  NR  1
Nigeria, Cross River(25)  2007  MSM  NR  1  IA  10  10  4.00  NR  293  2
Nigeria, Cross River(26)  2010  PWID  NR  >1  IA  10  10  4.00  4.00  266  2
Nigeria, Federal Capital 
Territory(26) 
2010  PWID  NR  >1  IA  10  10  4.00  4.00  266  2
Nigeria, Ibadan(27)  2006  MSM  NR  NR  IA  38  38  4.00  NR  NR  1
Nigeria, Ibadan(24)  2010  MSM  NR  NR  SA ACASI/SA NR  NR  NR  NR  NR  2
Nigeria, Kaduna(26)  2010  PWID  NR  >1  IA  10  10  4.00  4.00  266  1
Nigeria, Kano(26)  2010  PWID  NR  >1  IA  10  10  4.00  4.00  266  2
Nigeria, Kano(25)  2007  MSM  NR  1  IA  10  10  4.00  NR  293  3
Nigeria, Lagos(25)  2007  MSM  NR  1  IA  10  14  4.00  NR  293  2
Nigeria, Lagos(26)  2010  PWID  NR  >1  IA  10  10  4.00  4.00  266  1
Nigeria, Lagos(27)  2006  MSM  NR  NR  IA  38  38  4.00  NR  NR  1
Nigeria, Lagos(24)  2010  MSM  NR NR SA ACASI/SA NR NR  NR  NR NR 3
Nigeria, Oyo(26)  2010  PWID  NR  >1  IA  10  10  4.00  4.00  266  2
Mauritius(28)  2009  PWID  Yes  2  IA  6  6  7.00  3.50  500  5
Mauritius(29)  2010  FSW  NR  2  IA  5  5  17.50  7.00  NR  2
Somalia, Hargeisa, 
Somaliland(30) 
2008  FSW  Yes  1  IA w/ HAPI  6  NR  4.00  3.00  146  2













































Sudan, Khartoum(39)  2008  FSW  NR  1  IA  NR  NR  10.00  10.00  NR  3
Tanzania, Zanzibar(40,41)  2007  MSM  Yes  1  IA  10  10  3.00  1.50  500  5
Uganda, Kampala(42)  2008‐09  MSM  Yes  1  ACASI  8  14  3.00  1.00  600  3
Eastern Mediterranean                               
Egypt, Cairo(43)  2006  IDU  Yes  1  IA  28  NR  7.00  5.30  406  4
Iran, Kerman(44)  2010  FSW  NR  1  IA  8  12  4.00  2.00  NR  1
Lebanon, Beirut(45,46)  2007‐08  FSW  NR  NR  NR  NR  NR  6.60  2.00  NR  1
Lebanon, Beirut(45)  2007‐08  MSM   NR  NR  NR  NR  NR  6.60  2.00  NR  1
Lebanon, Beirut(45,47)  2007‐08  PWID  NR  NR  NR  NR  NR  6.60  2.00  NR  8
Libya, Tripoli(48)  2010  PWID  Yes  1  IA  7  7  20.00  9.00  NR  3
Libya, Tripoli(49)  2010  MSM  Yes  1  IA  NR  14  NR  NR  NR  2
Libya, Tripoli(49)  2010  FSW  Yes  1  IA  NR  13  NR  NR  314  6
Morocco, Agadir(50)  2010‐11  MSM  NR  NR  IA  NR  10  7.00  3.50  NR  3
Morocco, Marrakesh(50)  2010‐11  MSM  NR  NR  SA  NR  8  7.00  3.50  NR  3
Palestine, East Jerusalem(51) 2010  PWID  Yes  1  IA  NR  7  NR  NR  NR  1
Europe                     
Albania, Tirana(52)  2005  PWID  Yes  3  IA  15  15  12.00  7.00  NR  2
Albania, Tirana(53)  2008  MSM  NR  1  IA   12  NR  10.00  5.00  NR  1
Croatia, Zagreb(54–56)  2006  MSM  NR  1  SA  8  10  18.00  9.00  400  3
Croatia, Zagreb(54)  2012  MSM  Yes  1  SA  10  15  None  9.60  370  4
England, Bristol(57,58)  2006  PWID  NR  NR  CASI  7  7  15.00  10.00  NR  2
England, Bristol(57)  2009  PWID  NR  NR  NR  6  6  NR  NR  NR  2
Estonia, Kohtla Jarve(59,60)  2005  PWID  NR  NR  SA  NR  NR  NR  NR  NR  1










Estonia, Tallinn(60,65)  2005  PWID  NR  NR  SA  6  NR  NR  NR  NR  3





Kazakhstan, Almaty(66)  2010  MSM  Yes  NR  IA   4  4  10.00  2.50  400  4
Moldova, Balti(67)  2009‐10  FSW  NR  NR  IA  5  5  7.00  5.00  350  3
Moldova, Balti(68)  2007‐08  PWID  Yes  NR  IA  NR  NR  Items, cash 
(value NR) 
NR  NR  3
Moldova, Balti(69)  2010  MSM  Yes  NR  IA   5  5  8.30  5.80  250  2
Moldova, Chisinau(68)  2007‐08  PWID  Yes  NR  IA  NR  NR  Items, cash 
(value NR) 
NR  NR  3
Moldova, Chisinau(67)  2009‐10  FSW  NR  NR  IA   5  5  16.00  12.00  350  2
Moldova, Chisinau(69)  2010  MSM  Yes  NR  IA   8  8  8.30  5.80  250  1
Moldova, Tiraspol(68)  2007‐08  PWID  Yes  NR  IA  NR  NR  Items, cash 
(value NR) 
NR  NR  3
Montenegro, Podgorica(70)  2008  PWID  NR  1  SA  5  NR  20.80  7.00  NR  3
Montenegro, Podgorica(71)  2005  PWID  NR  1  ACASI  NR  NR  13.00  6.00  NR  3












2005‐08  PWUD/PWID  NR  NR  CASI  48; 108 156  10.00 (items)  items (value 
NR) 
NR  6
Russia, St. Petersburg(74,75) 2005‐06  PWID  NR  NR  CASI  35  NR  10.00 (items)  NR  NR  3
Serbia, Belgrade(76)  2010  Youth  Yes  NR  IA   8  8  13.00  6.00  371 ¶  2
Serbia, Belgrade(71)  2005  PWID  NR  1  ACASI  NR  NR  13.00  6.00  NR  4
Serbia, Kragujevac(76)  2010  Youth  Yes  NR  IA   4  4  13.00  6.00  370 ¶  1
Ukraine, Poltava(77)  2011  PWID  NR  NR  SA   4  4  3.00  2.00  NR  2
Ukraine, Khmelnitsky(77)  2011  PWID  NR NR SA  7 7 3.00  2.00 NR 2
Ukraine, Dnipropetrovsk(77)  2011  PWID  NR NR SA  6 6 3.00  2.00 NR 1
Ukraine, Cherkasy(77)  2011  PWID  NR  NR  SA   3  3  3.00  2.00  NR  1
Ukraine, Donetsk(77)  2011  PWID  NR  NR  SA   6  6  3.00  2.00  NR  4
Ukraine, Kharkov(77)  2011  PWID  NR  NR  SA   5  5  3.00  2.00  NR  1
Ukraine, Kherson(77)  2011  PWID  NR  NR  SA   4  4  3.00  2.00  NR  2
Ukraine, Kirovograd(77)  2011  PWID  NR  NR  SA   4  4  3.00  2.00  NR  1
Ukraine, Kyiv(77)  2011  PWID  NR  NR  SA   8  8  3.00  2.00  NR  4
Ukraine, Lugansk(77)  2011  PWID  NR  NR  SA   6  6  3.00  2.00  NR  2
Ukraine, Lutsk(77)  2011  PWID  NR  NR  SA   4  4  3.00  2.00  NR  1
Ukraine, Lviv(77)  2011  PWID  NR  NR  SA   7  7  3.00  2.00  NR  1
Ukraine, Mykolaiv(77)  2011  PWID  NR  NR  SA   6  6  3.00  2.00  NR  2
Ukraine, Odesa(77)  2011  PWID  NR  NR  SA   6  6  3.00  2.00  NR  4
Ukraine, Simferopol(77)  2011  PWID  NR  NR  SA   5  5  3.00  2.00  NR  2
Ukraine, Sumy(77)  2011  PWID  NR  NR  SA   5  5  3.00  2.00  NR  1
Latin America and Caribbean                           
Argentina, Buenos 
Aires(78,79) 
2009  MSM  NR  NR  SA web‐
based  
16  16  NR  NR  NR  5
Brazil, Belo Horizonte(80–
82) 
2009  MSM  Yes  NR  IA  6  NR  10.00  6.67  350  N
Brazil, Belo Horizonte(17,83) 2008‐09  FSW  NR  NR  ACASI  5 to 10  NR  Misc. (value NR) 4.00  300  2
Brazil, Brasilia(80–82)  2009  MSM  Yes  NR  IA  6  NR  10.00  6.67  350  N
Brazil, Brasilia(17,83)  2008‐09  FSW  NR  NR  ACASI  5 to 10  NR  Misc. (value NR) 4.00  300  3
Brazil, Campinas(84)  2005‐06  MSM  NR  NR  ACASI  10  30  NR  NR  NR  6
Brazil, Campo Grande(80–
82) 
2009  MSM  Yes  NR  IA  6  NR  10.00  6.67  350  N
Brazil, Campo Grande(17,83) 2008‐09  FSW  NR NR ACASI 5 to 10 NR  Misc. (value NR) 4.00 150 1
Brazil, Curitiba(80–82)  2009  MSM  Yes  NR  IA  6  NR  10.00  6.67  350  N
Brazil, Curitiba(17,83)  2008‐09  FSW  NR  NR  ACASI  5 to 10  NR  Misc. (value NR) 4.00  200  2
Brazil, Fortaleza(85)  2008  Transvestite  Yes  NR  IA  6  NR  6.00 food 
voucher 
3.00  NR  3
Brazil, Fortaleza(86)  2005  MSM  Yes  2  IA  10  10  5.00  5.00  400  4
Brazil, Itajaí(80–82)  2009  MSM  Yes  NR  IA  6  NR  10.00  6.67  350  N
Brazil, Itajaí(17,83)  2008‐09  FSW  NR  NR  ACASI  5 to 10  NR  Misc. (value NR) 4.00  100  9
Brazil, Manaus(80–82)  2009  MSM  Yes  NR  IA  6  NR  10.00  6.67  350  N
Brazil, Manaus(17,83)  2008‐09  FSW  NR  NR  ACASI  5 to 10  NR  Misc. (value NR) 4.00  200  1
Brazil, Recife(80–82)  2009  MSM  Yes  NR  IA  6  NR  10.00  6.67  350  N
Brazil, Recife(17,83)  2008‐09  FSW  NR  NR  ACASI  5 to 10  NR  Misc. (value NR) 4.00  200  2
Brazil, Rio de Janeiro(80–82)  2009  MSM  Yes  NR  IA  6  NR  10.00  6.67  350  N
Brazil, Rio de Janeiro(17,83)  2008‐09  FSW  NR  NR  ACASI  5 to 10  NR  Misc. (value NR) 4.00  600  6
Brazil, Salvador(80–82)  2009  MSM  Yes  NR  IA  6  NR  10.00  6.67  350  N
Brazil, Salvador(17,83)  2008‐09  FSW  NR  NR  ACASI  5 to 10  NR  Misc. (value NR) 4.00  300  2
Brazil, Santos(80–82)  2009  MSM  Yes  NR  IA  6  NR  10.00  6.67  350  N
Brazil, Santos(17,83)  2008‐09  FSW  NR  NR  ACASI  5 to 10  NR  Misc. (value NR) 4.00  150  1
Dominican Rep., 
Barahona(87) 
2008  MSM  Yes  NR  IA  8  NR  9.00  3.00  300  2
Dominican Rep., La 
Altagracia(87) 
2008  MSM  Yes  NR  IA  7  NR  9.00  3.00  300  2
Dominican Rep., 
Santiago(87) 
2008  MSM  Yes  NR  IA  6  NR  9.00  3.00  300  3
Dominican Rep., Santo 
Domingo(87)  
2008  MSM  Yes  NR  IA  7  NR  9.00  3.00  500  5
El Salvador, San 
Miguel(88,89) 
2008  MSM  Yes  NR  CASI w/ 
interviewer 
5  5   4.00 as items  2.70 (items)  200  1
El Salvador, San Salvador(89) 2008  FSW  NR  1  CASI w/ 
interviewer 





2008  MSM  Yes  NR  CASI w/ 
interviewer 
11  11  4.00 as items  2.70 (items)  600  5
El Salvador, Sonsonate(89)  2008  FSW  NR  1  CASI w/ 
interviewer 
5  5  Items (value NR) Items (value 
NR) 
NR  7





Honduras, La Ceiba(90)  2006  FSW  Yes 1 ACASI 7 7 "  " 200 2
Honduras, San Pedro 
Sula(90) 
2006  FSW  Yes  1  ACASI  7  7  "  "  200  1
Honduras, Tegucigalpa(90)  2006  FSW  Yes  1  ACASI  5  5  "  "  200  2
Peru, Lima(91)  2012  Transwoman  Yes  6  SA  8  11  7.00  NR  420  4
North America                               
Mexico, Juarez(92–96)  2005  PWID  NR 1 SA NR NR  NR  NR NR 2
Mexico, Juarez(97)  2005  PWID  NR 1 SA 9 17  20.00  5.00 200 1
Mexico, Tijuana(92–96)  2005  PWID  NR  3  SA  15  15  10.00  5.00  200  2
Mexico, Tijuana(98–102)    2006‐07  PWID  NR  NR  SA  32  NR  20.00  NR  NR  1
USA, Appalachia(103)  NR  DU  NR  NR  NR  NR  NR  50.00  10.00  NR  5
USA, Atlanta(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  5
USA, Baltimore(104)  2002‐04  Youth IDU  NR  NR  ACASI, w/   
w/out 
interviewer 
NR  NR  NR  NR  NR  7
USA, Baltimore(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  7
USA, Baltimore(105)  2006  PWID  NR  NR  CAPI  20  20  20.00  10.00  NR  6
USA, Boston(106,107)  2008  MSM  NR  2  SA  8  21  50.00  10.00  NR  1
USA, Boston(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  4
USA, Chicago(104)  2002‐04  Youth IDU  NR  NR  ACASI, w/   
w/out 
interviewer 
NR  NR  NR  NR  NR  5
USA, Chicago(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  5
USA, Dallas(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  5
USA, Denver(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  5
USA, Detroit(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  5
USA, Ft. Lauderdale(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  3
USA, Houston(6)  2005‐06  PWID  NR NR SA 8 to 10 NR  25.00  10.00 NR 5
USA, Houston(108)  2006‐07  High risk 
heterosexuals 
Yes  1  CAPI  NR  NR  40.00  10.00  750  9
USA, Las Vegas(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  3





NR  1  ACASI    25  25  50.00  20.00  NR  4
USA, Miami(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  6
USA, Nassau(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  5
USA, New Haven(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  5
USA, Las Cruces(97)  2005  PWID  NR  1  SA  NR  NR  NR  NR  NR  1
USA, New York City(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  5





Yes  NR  SA  8  NR  30.00  11.00  NR  8
USA, New York 
City(1,119,120) 
2004  DU  NR  NR  NR  NR  NR  20.00  10.00  NR  4
USA, Newark(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  4




Yes  4  SA  48  NR  10.00 gift card  Varied   NR  2
USA, Philadelphia(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  5
USA, San Diego(122)  2009‐10  PWID  NR  NR  ACASI  NR  NR  NR  10.00  NR  5
USA, San Diego(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  5
USA, San Francisco(123)  2007‐08  MSM  Yes  1  CAPI    10  10  40.00  10.00  NR  2
USA, San Francisco(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  5
USA, San Juan(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  5
USA, Seattle(124)  2009  PWID  NR  1  IA  6  6  40.00  10.00  NR  4
USA, Seattle(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  4
USA, St. Louis(6)  2005‐06  PWID  NR  NR  SA  8 to 10  NR  25.00  10.00  NR  5
USA, Wash. DC(125)  2006‐07  High risk 
heterosexuals 
Yes  1  SA  NR  NR  35.00  10.00  NR  7
USA, Wash. DC(126)  2009  PWID  NR  1  SA   NR  NR  30.00  10.00  NR  5
USA, Texas, El Paso(97)  2006  PWID  NR  1  SA  NR  NR  NR  NR  NR  1
South East Asia                              
Bangladesh, Dhaka(127)  2006  MSM  Yes  1  SA  5  8  2.14  1.43  530  5
India, Bishenpur District, 
Manipur(128) 
2006  PWID  NR   NR  SA  NR  NR  NR  NR  400  4
India, Chennai(129)  2008  MSM  Yes  2  SA  NR  19  6.00  None  NR  7
India, Churachandpur 
District, Manipur(128) 
2006  PWID  NR   NR  SA  NR  NR  NR  NR  400  4
India, Coimbatore(129)  2008  MSM  Yes  1  SA  NR  19  6.00  None  NR  7
India, Dimapur District, 
Nagaland(130) 
2006  FSW  NR   NR  SA  10  10  NR  NR  400  4
India, Dindigul(129)  2008  MSM  Yes 1 SA NR 19  6.00  None NR 7
India, Erode(129)  2008  MSM  Yes  1  SA  NR  19  6.00  None  NR  7
India, Goa(131,132)  2005  FSW  Yes  NR  SA  59  59  2.50  1.50  318  3
India, Kanyakumari(129)  2008  MSM  Yes  1  SA  NR  19  6.00  None  NR  7
India, Madurai(129)  2008  MSM  Yes  1  SA  NR  19  6.00  None  NR  7
India, Mumbai & Thane 
Districts(128) 
2006  PWID  NR   NR  SA  NR  NR  NR  NR  400  3
India, Nagapattinam(129)  2008  MSM  Yes  1  SA  NR  19  6.00  None  NR  7
India, Nilgiris(129)  2008  MSM  Yes  1  SA  NR  19  6.00  None  NR  7
India, Perambalur(129)  2008  MSM  Yes  1  SA  NR  19  6.00  None  NR  7
India, Phek District, 
Nagaland(128) 
2006  PWID  NR   NR  SA  NR  NR  NR  NR  400  4
India, Pudukottai(129)  2008  MSM  Yes  1  SA  NR  19  6.00  None  NR  7
India, 
Ramanathapuram(129) 
2008  MSM  Yes  1  SA  NR  19  6.00  None  NR  7
India, Salem(129)  2008  MSM  Yes  1  SA  NR  19  6.00  None  NR  7
India, Sivagangai(129)  2008  MSM  Yes  1  SA  NR  19  6.00  None  NR  7
India, Thanjavur(129)  2008  MSM  Yes  1  SA  NR  19  6.00  None  NR  7
India, Tiruchy(129)  2008  MSM  Yes  1  SA  NR  19  6.00  None  NR  7
India, Tirunelveli(129)  2008  MSM  Yes  1  SA  NR  19  6.00  None  NR  7
India, Tiruvarur(129)  2008  MSM  Yes  1  SA  NR  19  6.00  None  NR  7
India, Tuticorin(129)  2008  MSM  Yes  1  SA  NR  19  6.00  None  NR  7
India, Wokha District, 
Nagaland(128)  
2006  PWID  NR   NR  SA  NR  NR  NR  NR  400  4
Pakistan, Abbottabad(133)  2007  MTSW  Yes  2  IA  NR  NR  NR  NR  NR  1
Pakistan, Abbottabad(133)  2007  FSW  Yes  2  IA  NR  NR  NR  NR  NR  1
Pakistan, Lahore(133)  2007  FSW  Yes 3 SA 3 NR  NR  NR 726 7
Pakistan, Rawalpindi(133)  2007  MTSW  Yes 2 IA NR NR  NR  NR NR 8
Pakistan, Rawalpindi(133)  2007  FSW  Yes  2  IA  NR  NR  NR  NR  NR  4
Thailand, Bangkok(134)  2007  FSW  NR  3  ACASI, with/  
w/out 
interviewer 
15  15  11.80  1.50  NR  7
Western Pacific                                 
China, Beijing(135)  2009  MSM  NR  1  ACASI    7  7  4.50  3.00  NR  5
China, Beijing(3)  2004  MSM  NR  1  SA  1  1  None  2.10  NR  3
China, Beijing(3,136)  2005  MSM  NR  1  SA  10  10  None  2.10  NR  4
China, Beijing(3)  2006  MSM  NR  1  SA  8  8  None  2.10  NR  5
China, Beijing(137)  2009  MSM  NR  1  CAPI  7  8  5.00  3.20  NR  5
China, Chongqing(138)  2009  MSM  NR  NR  CASI  7  7  4.50  3.00  NR  5
China, Guangdong(139)  2008  PWID  Yes  1  SA  6  7  7.50  3.00  238  2
China, Guangdong(140)  NR  FSW  NR  1  IA or CASI  4  4  NR  NR  NR  3
China, Guangzhou(141)  2008  MSM  NR  1  SA  13  13  5.00, gift/cash   1.50  NR  3
China, Jinan(142,143)  2007  MSM  Yes  1  SA  9  9  None  NR  428  4
China, Jinan(142,143)  2008  MSM  Yes  1  SA  5  5  None  NR  500  5
China, Jinan(144)  2008  FSW  Yes  1  SA  7  7  7.30  2.90  NR  3
China, Jinan(144)  2009  FSW  Yes  1  SA  4  4  7.30  2.90  NR  4
China, Liuzhou(145,146)  2009‐10  FSW  Yes  1  SA  7  8  14.00  7.00  380  5
China, Nanjing(147)  NR  MSM  NR  1  NR  9  9  4.00 phone card NA  NR  4
China, Shandong(148)  2007‐08  Money boys  NR  NR  SA  16  NR  NR  NR  120  1
Indonesia, Bandung(149)  2007  IDU  NR  NR  SA  8  NR  NR  4.00  250  2
Indonesia, Surabaya(149)  2007  IDU  NR  NR  SA  8  NR  NR  4.00  250  2
Vietnam, Cam Ranh(150)  2005  MSM  NR  1  NR  2  NR  1.90  0.95  300  2
Vietnam, Dien Khanh(150)  2005  MSM  NR  1  NR  2  NR  1.90  0.95  300  2
Vietnam, Hai Phong(150)  2004  FSW  NR  NR  SA  20  25  3.00  1.00  200  2
Vietnam, Ho Chi Minh 
City(150) 
2004  FSW  NR  NR  SA  20  24  4.00  1.50  400  4
Vietnam, Nha Trang(150)  2005  MSM  NR  1  NR  2  NR  1.90  0.95  300  2
Vietnam, Ninh Hoa(150)  2005  MSM  NR  1  NR  2  NR  1.90  0.95  300  2




We examined peer-reviewed literature published in physical or on-line journals that 
reported using RDS and were either accessible through September, 2013, or were 
identified from a previously conducted search (22). Searches were conducted using 
MEDLINE (1997-2013), EMBASE (1997 -2013), and Global Health (1997-2013). Search 
terms included “respondent driven”, “respondent-driven” or “RDS”. The original 
extraction included surveys in any country, in any language, and among any study 
population that reported using RDS (n=4562). Articles excluded in the initial extraction 
were those that were duplicates (n=2360), irrelevant (e.g., protocols, presentations, 
flyers, etc.; n=1716) and either reviews, opinion pieces, editorials, commentaries and 
papers strictly addressing RDS methodology (n=44, i.e., those not intending to report 
population based estimates). This resulted in a total of 442 articles and abstracts. We 
further refined our search by eliminating abstracts (n=58) and publications that were 
either duplicated (n=3), non-English (n=40), without biological data (n=167), or claimed 
to, but did not, use RDS (n=23). When there were a number of publications for a single 
study, all related publications were reviewed to update the extraction sheet. This 
resulted in 151 articles representing 222 surveys (Figure 1).  
Categorizing documents and extraction 
We selected and extracted key data from 151 journal articles and entered them into a 
master table in Excel® into rows specific to the survey(s) described. Journal data 
entered into the table were organized into seven sub-tables based on WHO 
categorization of regions: Africa, Eastern Mediterranean (EM), Europe, Latin America 
and the Caribbean (LAC), North America, South-East Asia (SEA), and Western Pacific. 
We extracted information considered essential for assessing RDS-specific survey 
quality as reported in Malekinejad et al (4), Montalegre et al (5) and White et al (21,22) 
in each publication. The indicators reviewed included those informing survey design and 
implementation and analysis. Indicators informing survey design and implementation 
are the survey year, eligibility criteria, specimen type collected for biological testing, 
whether pre-survey research was conducted, number of recruitment sites, interview 
method, number of seeds at the start and end (and whether seeds were added or failed 
during data collection) of the survey, amount or type of primary and secondary 
incentives (USD), calculated target and final sample size, design effect used for sample 
size calculation, maximum number of waves, duration of data collection (in weeks), and 
maximum number of coupons distributed to each recruiter. Indicators informing analysis 
are whether equilibrium or convergence was assessed, whether data were adjusted for 
network size, software used, and the citation and estimator used for adjustment. The 
rationale for selecting these indicators, including their usefulness in any survey versus 
specifically for RDS surveys, are provided in Table II.  







Rational for reporting 
Indicators N 
(222) 
% Median (range)  
Year of survey 219 99 -- Useful for any survey in order 
to know how current data are, 
to plan future surveys and to 
compare data from other 
surveys. 
Eligibility criteria 
(minimum of behavior 
description) § 
222 97 -- Useful for any survey to 
determine the denominator 
being measured, to know 
measurement for the 
construction of the social 
network question needed for 
RDS analysis. Provides readers 
with possible criteria to use in 
different populations and 
settings; allows for comparison 
of data across countries. 
Type of specimen 
collected for biological 
testing §  
193 87 -- Useful for any survey. Informs 
readers about the types of 
testing being conducted in 




88 40 -- Useful for any survey. Informs 
readers about the survey 
planning process, especially 
whether attempts were 
possibly made to assess the 
underlying network structure 
of the population. 
Number of recruitment 
sites per survey area 
95 43 1 (1-6) Especially useful in RDS as it 
alerts readers to the possible 
violation of the network being 
one complete component if 
participants at each site are not 
connected; informs readers 
about the possible clustering 
(or diffusion) of sample. 
Interview method 210 94 -- Useful for any survey. 
Provides information about 
level of confidentiality in the 
survey (i.e., ACASI may 
provide more confidentiality) 
and informs readers about the 
different types of methods 
used for interviewing hidden 
populations in RDS surveys. 
Number of seeds at the 
start of the survey  
62 28 7.5 (1-48) Specifically useful for RDS 
surveys. Informs readers about 
whether many seeds were 
added during data collection 
and the number of seeds in 
relation to the sample size and 
number of waves (too many 
seeds may result in too few 
waves needed to reduce seed 
dependence, adding too many 
seeds may be an indication that 
the population is not well 
Whether seeds were 
added during data 
collection 
17 8 5 (1-37) 
Whether seeds failed 
during data collection 
14 6 4 (1-24) 
Number of seeds by the 
end of the survey 
121 54 10 (1-156) 
networked); provides 
parameters for readers about 
seeds needed in different 
populations and settings. 
Amount or type of 
primary incentive (USD) 
186 84 3 (1.9-5) ∗ Specifically useful for RDS 
surveys. Provides readers with 
parameters about amounts used 
in different populations and 
settings, provides an indication 
of potential bias during 
recruitment (if incentives are 
too high, more people may 
enroll who are not eligible). 
Having no primary 
incentive 
6 3 -- 
Amount or type of 
secondary incentive 
(USD) 
177 80 10 (0.95-20) † 
 Having no secondary 
incentive 
18 8 -- 
Calculated target sample 
size 
89 40 300 (100-756) Useful for any survey. 
Indicates if an original sample 
size was calculated and if that 
sample size was reached in 
order to ensure sufficient 
power and confidence for data 
analysis. Provides readers with 
parameters about sample sizes 
used in different populations 
and settings. Specific for RDS 
Final sample size 212 95 325 (100-1056)‡ 
Final sample size for 
multiple cities combined 
28 12 -- 
surveys: combining multiple 
survey sites is often a violation 
of the network being one 
network component.  
Design effect used for 
sample size calculation § 
50 22 2 (1.3-3) design effects, currently 
recommended to be at least 2 
(151,152,16), are important for 
calculating a sufficient sample 
size to account for RDS not 
being a traditional random 
sample 
Maximum number of 
waves 
95 43 9 (3-21)  
Duration of data 
collection (in weeks) 
139 63 12 (2-124) Informs readers of the time 
needed to gather samples of 
different sizes from different 
populations and settings; alerts 
readers of unusual recruitment 
lengths that may impact 
representativeness of the 
sample. 
Maximum number of 
coupons distributed to 
each recruiter § 
163 73 3 (2-7) Specifically useful for RDS 
surveys. The number of 
coupons used are normally 
three (7), but some surveys 
have used more. Analysis does 
not account for branching 
induced by the number of 
coupons provided to each 
participant so fewer coupons, 
when possible, is suggested to 
mimic a random walk process. 
Whether equilibrium or 
convergence was 
assessed§ 
44 20  Specifically useful for RDS 
surveys. Informs readers of 
seed dependence and is a 
diagnostic to assess bias. 
Whether data were 
adjusted for network size 
157 70 -- Specifically useful for RDS 
surveys. Informs readers of the 
extent to which RDS was fully 
utilized, resulting in the ability 
to assess whether the survey 
may represent the network of 
the population from which the 
sample was gathered 
Software used to adjust 
data § 
162 73 -- Specifically useful for RDS 
surveys. There are limited 
software packages available 
for analyzing RDS data. 
Analyzing RDS data in more 
popular, preexisting software 
(i.e., STATA, SPSS) may not 
eliminate RDS specific biases.  
Citation for adjustment § 59 26 -- Specifically useful for RDS 
surveys. Given the evolvement 
of the estimators for the 
analysis of RDS data, this is 
useful for providing 
information about the 




19 32 -- 
Salganik & 
Heckathorn (12) § 
28 47 -- 
Heckathorn (11) § 10 17 -- 
Volz & 
Heckathorn (13) § 
7 12 -- 
Gile (154) § 4 7 -- 
Estimator used for 
adjustment § 
10 4 -- 
Whether seeds were 
discarded during analysis 
31 14 -- Some studies either did not 
collect data from seeds or did 
not include their data their 
analysis, which could likely 
result in the sample having 
addition seeds (analysis would 
assume wave 1 participants are 
seeds) thereby potentially 
impacting seed dependence 
and biasing the final estimate.  
 
Analysis 
Frequencies were used to characterize the surveys and their contents. We conducted 
robust and logistic regressions of survey start year and pre-survey research, eligibility 
age, number of seeds at the start and end of survey, survey duration, final sample size, 
estimated design effect, length of longest recruitment chain, and adjustment of RDS to 
assess linear trends in the value of these indicators over time (155). Design effects 
were calculated for surveys that presented a point estimate for HIV prevalence, 95% 
confidence intervals and the final sample size. The calculation for design effects 
consisted of dividing the widths of the confidence interval by two, dividing again by 1.96 
(the standard normal value corresponding to a central area of 95%), and squaring the 
final number. 
RESULTS 
The identified published articles of RDS surveys were conducted in the following WHO 
regions: 21 from Africa (28 surveys), 12 from EM (11 surveys), 30 from Europe (44 
surveys), 17 from LAC (37 surveys), 41 from North America (45 surveys), 12 from SEA 
(32 surveys), and 18 from the Western Pacific (25 surveys). Extracted surveys included 
85 among PWID, 78 among MSM and 38 among FSW. Surveys of other groups 
included people who use and/or inject drugs (n=2), male sex workers (n=3), high-risk 
heterosexuals (n=7), transgender (n=2), and youth (n=3). The remaining surveys were 
of mixed groups such as youth PWID (n=2), people who use and/or inject drugs 
together (n=1) and MSM who use and/or inject drugs (n=1). 
Assessing reports of survey quality 
Survey data extracted from published articles included in this review were used to 
assess whether RDS recruitment and analysis were conducted, but the details provided 
for these surveys varied across articles. For instance, all published surveys reported 
basic implementation information such as the city, country and the population sampled, 
and 99% reported the survey year (Table II). Over 90% of surveys reported the 
interview technique (e.g., face-to-face questionnaire, computer-assisted self-interviews, 
etc.) (94%), final sample size (95%) and at least the behavioral component of the 
eligibility criteria (97%). Eighty four percent reported the primary and 80% reported the 
secondary incentive amounts or types, and 73% reported the maximum number of 
coupons given to each recruiter. Sixty-three percent reported the data collection 
duration, 40% reported whether pre-survey research was conducted, 43% reported the 
number of recruitment sites used and the maximum number of waves, 40% reported the 
target sample size, 22% reported the design effect used for calculating the sample size. 
For those surveys that presented both calculated and final sample sizes (n=77, 35%), 
the median percentage difference was 1.0 (range 0.2-1.6). There was no significant 
difference in this measure over time among all populations combined or by population. 
Seventy percent reported whether data were adjusted for network size, 73% 
reported the type of software used to adjust data (74% of which used RDS Analysis 
Tool [RDSAT]) and 26% cited the statistical adjustment, among which 47% cited 
Salganik & Heckathorn (12), 32% cited Heckathorn (10) and/or 2002, 17% Heckathorn 
(11), 12% Volz & Heckathorn (13) and 7% Gile (14,154). Only 20% of surveys reported 
whether equilibrium or convergence was assessed and 4% reported which estimator 
was used for their statistical adjustment. Thirty-one surveys (14%) specifically reported 
discarding seeds from their analysis. 
Design effects for HIV 
Of the 222 surveys reviewed, 185 reported HIV prevalence point estimates above 0, 
136 included 95% confidence bounds, and 210 reported final sample sizes. Ninety-five 
surveys (42.7%) included all three elements to enable calculation of the estimated 
design effect for HIV prevalence. Four (4.2%) had a design effect less than 1.0, 28 
(29.5%) had a design effect of 1.0, 46 (48.4%) had a design effect of 2. The remaining 
design effects were as high as 5.9, indicating that a larger sample size was needed to 
estimate HIV prevalence.  
Assessing changes over time 
In assessing changes over time (Table III), we found significant decreases in eligibility 
age, final number of seeds, and final sample size (p<0.01, for all) and significant 
increases in pre-survey research and using a design effect to calculate the target 
sample size (p<0.01). There were no significant changes for survey duration even when 
adjusting for target population and final sample size. Nor were there significant changes 
by year for survey duration or length of longest recruitment chain.  
DISCUSSION 
Reporting on details of survey design, implementation, and analysis is essential 
for assessing the quality of RDS surveys and findings. It is important to adequately 
describe both the methodological and analytical aspects of RDS in any publication. The 
preponderance of publications from surveys reported the most essential information 
such as survey city, country, year, population sampled, interview method, and final 
sample size. Given that all publications from surveys reported collecting biological 
specimens, it is surprising that 13% did not provide information about specimen 
collection and testing methods. Gaps in reporting RDS methodological and analytical 
information made it difficult to assess survey quality and the strength of results. RDS 
does not work in all situations and failure to meet assumptions should be noted. For 
instance, only 43% of surveys reported the maximum number of waves and 20% 
reported assessment of equilibrium or convergence, information needed to assess 
potential biases. Among those surveys reporting their maximum number of waves, 
some reported having only a maximum of three waves, indicating that the survey results 
were likely biased by the non-randomly selected seeds.   
Although pre-survey research should be part of any survey, it is increasingly 
recognized as an important part of any RDS survey (7,15,22,156), as evidenced by the 
increase in surveys reporting having conducted formative research. Because RDS 
samples a social network, formative research is imperative to understand the underlying 
network structure of the sampled population. If the sampled network is fragmented or 
has isolated sub-groups, the chances of sampling more than one network are higher, 
possibly resulting in unstable estimates (15). Furthermore, pre-survey research data 
can help investigators plan survey operations and encourage participation by learning 
about which survey procedures would be most acceptable to the target population. It is 
possible that the increased use of pre-survey research helped improve recruitment and 
led to the decrease in the final number of seeds reported over time. Fewer seeds 
generally occur concomitantly with longer chains, which in turn means decreased bias 
stemming from seed dependence. We recommend that all surveys using RDS conduct 
pre-survey research to evaluate social networks, as well as to assess the feasibility of 
using RDS in a particular population. 
Although 70% of surveys reported whether data were adjusted for network size 
and 73% reported the software used to adjust those data, few cited the adjustment 
procedure and even fewer reported the estimator used. There are currently at least five 
different estimators for adjusting RDS data (157). Given that many of the reviewed 
articles were written before the existence of some estimators, it is understandable that 
earlier publications did not cite the estimator used for analysis. Forthcoming publications 
should cite the estimator since knowing this information will allow readers to know how 
adjustments were made, if they were made properly, and the assumptions supporting 
those adjustments.  
Several publications reported discarding seeds from analysis. While it has been 
written that “seeds are eliminated from analysis” (13,153), this is not to say that seeds 
should be manually eliminated from a dataset. The RDS-I and RDS-II estimators (11–
13,153) use a matrix of recruits and recruiters whereby data from the recruits are 
necessary for calculating inclusion probabilities used to derive final estimates. Even 
though the seeds do not technically show up in the probability matrix since they were 
never recruited by their peers, their data are nonetheless necessary for establishing the 
placement of the seeds’ recruits in the matrix.   
We found an increase over time in surveys reporting design effects, an element 
in the sample size calculations to account for RDS not being a simple random sample. 
Although recent publications have found that design effects of 3 or 4 would be optimal, 
in most situations, a design effect of 2 is sufficient and recommended (16,151,152). 
Because operational constraints, such as limited financial resources, often preclude 
large sample sizes for some RDS surveys, using a design effect greater than 2 may 
result in unfeasibly large sample sizes. Post-hoc design effects on key variables can 
help determine if sample sizes were large enough for the analysis and inform sample 
size calculations for follow-up surveys of the same population. As such it is useful for 
publications to include point estimates, 95% confidence intervals and final sample size 
to allow for the post-hoc estimation of design effects.  
Equilibrium or convergence was reported in only 20% of the articles reviewed. 
Equilibrium, the term most often used when referring to RDS surveys, measures the 
progression of waves to determine when the proportion for a characteristic approaches 
and remains stable in relation to the final sample statistic (10). Convergence, a more 
sensitive measurement, measures the progression of enrolling subjects to determine 
when the proportion for a characteristic approaches and remains stable in relation to the 
adjusted estimate (15). Nevertheless, the assessment of either equilibrium or 
convergence is useful for determining seed dependence, a typical bias found in chain 
referral sampling methods, and should be reported for publications reporting population 
estimates from RDS surveys (22).   
While most surveys reported a minimum eligibility age of 18 years (n=150), we 
found the minimum age decreased over time. Collecting HIV and other biological and 
behavioral data from younger key populations is important given they are 
disproportionately affected by HIV worldwide and are comprising a high percentage of 
new HIV infections (9,158).  
Our review has limitations. As in any systematic review, we are restricted by the 
completeness of our publication search and whether investigators published their 
surveys in peer-reviewed journals. Furthermore, we only included surveys that collected 
biological data leaving room for further evaluation of those surveys that reported using 
RDS and did not collect biological data. The number of peer-reviewed articles found 
reporting RDS surveys is far fewer than the actual number of surveys conducted. 
Although key data were missing from articles, this is in itself an important finding which 
supports the need to uniformly report results from RDS surveys. It also limited the scope 
of our analyses and introduced uncertainty into some of our other findings (22). We 
excluded articles clearly stating they either used RDS ‘recruitment’ only or did not fulfill 
necessary features of the method; however, we may have included some surveys that 
did not incorporate all RDS methodological and analytical features, given their 
incomplete reporting. In those instances, we classified the surveys as using RDS and 
included them in the extraction. Several of the 23 articles claiming to use RDS, but did 
not, reported using a ‘modified’ or ‘mixed methods’ RDS. However, they did not provide 
conclusive evidence such as the collection and use of personal network size data, 
recruitment ties (who recruited whom) and coupon quotas, and multiple recruitment 
waves. In several extracted publications, significant limitations were reported, including 
unprepared staff, numerous ineligible persons trying to participate, closing or moving 
survey sites during data collection, overly high incentives (possible indication of 
enrollment of ineligible participants) or too low, overcrowding at the interview site, failure 
to recruit important population sub-groups (i.e., females in PWID surveys, older MSM), 
incorrect or no social network question, and early survey termination due to finances or 
community disturbances (3,34,41,55,86,127,159). Presenting key limitations is useful 
for interpreting findings and should be included in all publications presenting data from 
RDS surveys.   
The majority of published surveys were from North American and Europe; it 
would be useful to see more publications of RDS survey results from other regions. Not 
only could experiences from these different settings help researchers improve survey 
methods and analysis, but the results themselves could help policy makers, donors, and 
service providers to improve responses to HIV and other infection risk. Future 
publications of biological and behavioral surveys using RDS should provide a minimum 
set of parameters in order for readers to assess specific methodological and analytical 
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